Koulaouzidis Anastasios, Iakovidis Dimitris K, Karargyris Alexandros, Rondonotti Emanuele
Anastasios Koulaouzidis, The Royal Infirmary of Edinburgh, Endoscopy Unit, EH16 4SA Edinburgh, Scotland, United Kingdom.
World J Gastroenterol. 2015 May 7;21(17):5119-30. doi: 10.3748/wjg.v21.i17.5119.
Currently, the major problem of all existing commercial capsule devices is the lack of control of movement. In the future, with an interface application, the clinician will be able to stop and direct the device into points of interest for detailed inspection/diagnosis, and therapy delivery. This editorial presents current commercially-available new designs, European projects and delivery capsule and gives an overview of the progress required and progress that will be achieved -according to the opinion of the authors- in the next 5 year leading to 2020.
目前，所有现有的商用胶囊设备的主要问题是缺乏运动控制。未来，通过接口应用，临床医生将能够停止设备并将其引导至感兴趣的点进行详细检查/诊断以及治疗。这篇社论介绍了当前的商用新设计、欧洲项目和输送胶囊，并根据作者的观点概述了到2020年未来五年所需取得的进展和将会取得的进展。
